The global blood collection market is
expected to reach a value of USD 13.3 billion by 2025, according to a new
report by Grand View Research, Inc. The increasing incidence of infectious and
non-communicable diseases is a major factor anticipated to propel the market
growth during the forecast period. According to the Centers for Disease Control
and Prevention (CDC), in 2013, around 19.3 million people visited the
physician’s clinic for infectious and parasitic diseases testing in the U.S.
Moreover, according to International Diabetes Federation, 415 million people
suffered from diabetes in 2014 and this number is expected to rise up to 642
million by 2040. Thus, the increasing incidence of accidents and trauma cases
is another factor that drives the demand for blood collection products for therapeutic
application.
The increasing number of surgical
procedures is an additional key factor contributing to the growth. The
escalating number of accidental injury cases is expected to propel the demand
for target market products for therapeutics application. According to the CDC,
in the U.S, around 31.0 million patients visited emergency centers for
unintentional injuries in 2014. Thus, the demand for blood collection products
such as bags, needles, and syringes is growing at a high rate, which is expected
to boost the growth during the forecast period.
Browse full research report on Global Blood Collection Market: http://www.grandviewresearch.com/industry-analysis/blood-collection-market
Further Key Findings from
the Study Suggest:
- The needles and syringes segment was the largest grossing segment of the blood collection market in 2015 owing to the growing application of these devices in diagnosis and treatment of various disorders like diabetes and blood-related diseases
- The diagnostics application segment held the largest revenue share in 2015, owing to rising geriatric population and escalating prevalence of infectious & non-communicable diseases
- In 2015, the hospitals segment accounted for the largest share in the market due to an upsurge in the incidence of trauma & accidental cases along with growing number of surgical procedures
- North America held the largest share of the blood collection market in the year 2015. This region is estimated to uphold its dominance during the study period
- The presence of a highly developed healthcare infrastructure and advanced blood collection products is anticipated to boost the growth in North America during the forecast period
- Some of the key companies include Abbott Laboratories, NIPRO Medical Corp., Becton, Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL s.r.l.
Grand View Research has segmented the blood collection
market on the basis of product, application, end-use, and region:
Blood Collection Product Outlook (Revenue, USD Million;
2014 - 2025)
- Needles and Syringes
- EDTA Tubes
- Heparin Tubes
- Serum-Separating Tubes
- Plasma-Separating Tubes
- Blood Bags
- Others
Blood Collection Application Outlook (Revenue, USD
Million; 2014 - 2025)
- Diagnostics
- Treatment
Blood Collection End-Use Outlook (Revenue, USD Million;
2014 - 2025)
- Hospitals
- Diagnostics centers
- Blood banks
- Others
Blood Collection Regional Outlook (Revenue, USD Million;
2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment